Related references
Note: Only part of the references are listed.Perspectives in the treatment of pancreatic adenocarcinoma
Angel Cid-Arregui et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
W. Du et al.
ONCOGENE (2015)
Pancreatic cancer stromal biology and therapy
Dacheng Xie et al.
GENES & DISEASES (2015)
Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
Roman Mezencev
CURRENT CANCER DRUG TARGETS (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Evidence for the Importance of Personalized Molecular Profiling in Pancreatic Cancer
Loukia N. Lili et al.
PANCREAS (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
Pancreatic cancer: A comprehensive review and update
Thiruvengadam Muniraj et al.
DM DISEASE-A-MONTH (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Pancreatic cancer: why is it so hard to treat?
Paul E. Oberstein et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Invasive markers identified by gene expression profiling in pancreatic cancer
A. Rogers et al.
PANCREATOLOGY (2012)
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding-Wu Shen et al.
PHARMACOLOGICAL REVIEWS (2012)
Membrane Transporters as Mediators of Cisplatin Effects and Side Effects
Giuliano Ciarimboli
SCIENTIFICA (2012)
Activating Platinum Anticancer Complexes with Visible Light
Susan J. Berners-Price
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Camalexin induces apoptosis in T-leukemia Jurkat cells by increased concentration of reactive oxygen species and activation of caspase-8 and caspase-9
Roman Mezencev et al.
JOURNAL OF NATURAL MEDICINES (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clusterin confers gmcitabine resistance in pancreatic cancer
Qingfeng Chen et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
Elodie E. Noel et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Barnett Rosenberg: In Memoriam (1924-2009) Obituary
Bruce A. Chabner
CANCER RESEARCH (2010)
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells
Sanjeevani Arora et al.
DNA REPAIR (2010)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Daniele Merico et al.
PLOS ONE (2010)
Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes
W. Shi et al.
PHARMACOGENOMICS JOURNAL (2010)
Jun D cooperates with p65 to activate the proximal κB site of the cyclin D1 promoter:: role of PI3K/PDK-1
Kahina Toualbi-Abed et al.
CARCINOGENESIS (2008)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells
Timothy C. Cheng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase β
F Boudsocq et al.
MOLECULAR PHARMACOLOGY (2005)
Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells
PL Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Functional defects in the Fanconi anemia pathway in pancreatic cancer cells
MS Van der Heijden et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Role of MRIT/cFLIP in protection against chemotherapy-induced apoptosis
H Matta et al.
CANCER BIOLOGY & THERAPY (2002)
Overexpression of the human major vault protein in astrocytic brain tumor cells
W Berger et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
NF-κB signals induce the expression of c-FLIP
O Micheau et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Mechanisms of resistance to cisplatin
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells - Role of ERCC1-XPF
KV Ferry et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
